search
Back to results

Self-management of Blood Pressure Medication for Hypertensive Veterans

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
self-management protocol for hypertension care
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Hypertension

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Eligible participants are those with who have a clinical diagnosis of hypertension
  • Who are not currently at their in-clinic goal blood pressure (>130 or > 90 at minimum)
  • Are able to provide independent informed consent and expected to be in the area for at least 12 months

Exclusion Criteria:

  • Criteria for exclusion will include: active prescriptions for > 2 antihypertensive agents
  • Known allergies to 2 or more antihypertensive agents
  • Currently not primarily in charge of his/her own medication administration, e.g.:

    • those living in institutions or with dementia or other limitations making self medication care not possible
  • Life expectancy of less than 12 months
  • Blood pressure at screening visit > 180 mm Hg systolic or > 110 diastolic, or < 120 systolic
  • Screening cognitive function (Montreal Assessment of Cognitive Function, MoCA) 48 score less than 25
  • eGFR < 25 ml/min /1.73m2 or end-stage renal disease (ESRD)
  • Inability to use a standard home blood pressure cuff
  • Known secondary cause of hypertension that causes concern regarding safety of the protocol, in the opinion of the site investigator
  • Cardiovascular event or hospitalization for unstable angina within last 3 months
  • Symptomatic heart failure within the past 6 months or left ventricular ejection fraction < 35%
  • Pregnancy or planned pregnancy, or of child-bearing age not using birth control
  • Current participation in another clinical trial
  • Or major factors judged to be likely to significantly limit comprehension of or adherence to interventions including:

    • dementia
    • psychiatric disease
    • substance abuse

Sites / Locations

  • VA San Diego Healthcare System, San Diego, CA
  • San Francisco VA Medical Center, San Francisco, CA

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

self-management

usual care

Arm Description

Participants will be taught to monitor blood pressure and make limited adjustments to their medications

Participants will be enrolled in the study and undergo a baseline, 6 month, and 1 year visit but their hypertension care will be per usual care.

Outcomes

Primary Outcome Measures

in-clinic blood pressure change
Blood pressure as measured in clinic at start and end of study

Secondary Outcome Measures

24-hour ambulatory blood pressure change
Home (24 hour) ambulatory blood pressure change measured from start to end of study

Full Information

First Posted
July 11, 2017
Last Updated
April 18, 2023
Sponsor
VA Office of Research and Development
search

1. Study Identification

Unique Protocol Identification Number
NCT03224624
Brief Title
Self-management of Blood Pressure Medication for Hypertensive Veterans
Official Title
Self-management of Blood Pressure Medication for Hypertensive Veterans
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
February 21, 2018 (Actual)
Primary Completion Date
March 31, 2023 (Actual)
Study Completion Date
March 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Hypertension is the most common medical problem among US Veterans. Treatment is available and effective, but control rates remain under 75%. While blood pressure control has traditionally been achieved through sequential visits and medication changes initiated by providers during office-based care, self-monitoring and self-management of blood pressure medication is an important strategy that would empower Veterans to achieve better control of blood pressure. The health impacts of better systems for treatment of hypertension are significant, including decreased rates of cardiovascular and kidney disease. This two-site clinical trial will randomize 400 Veterans to either usual blood pressure care or a self-management strategy in which patient-driven self-management of blood pressure medications will be taught and used over the course of 1 year.
Detailed Description
Project background: Recent literature from the UK (TASMIN2 and TASMIN-SR trials) have suggested that patient-driven self-management of blood pressure medications can be effective in achieving hypertension control, but questions remain as to how to apply these findings to a US population. The VA Healthcare System is an ideal system in which to test and customize this strategy for blood pressure treatment. Project question: Is patient-initiated self-management of blood pressure medication using a pre-specified, generalizable dose escalation scheme clinically effective, safe, and acceptable to patients and clinicians, compared to usual care in controlling blood pressure in hypertensive Veterans? Project methods: The investigators propose a 12-month randomized, controlled, non-blinded, single-center study of patient-initiated self-management of blood pressure medication vs. usual care with planned post study cohort follow-up via medical records. Participants in the intervention arm will be provided with home blood pressure monitoring tools and a self-management algorithm for changing their blood pressure medications as needed. Participants in the usual care arm will receive home monitoring tools and typical hypertension care from the primary care provider. The primary blood pressure outcome measure for the study will be between-group change in in-clinic blood pressure. Acceptability, safety, patient-centered outcomes and adherence will be key secondary outcomes

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants will be randomized to either usual care or self-management of blood pressure using a stepped approach which participants can trigger using their home blood pressure measures.
Masking
Outcomes Assessor
Masking Description
The outcome (in clinic blood pressure) will be assessed without knowledge of which group participants were assigned.
Allocation
Randomized
Enrollment
123 (Actual)

8. Arms, Groups, and Interventions

Arm Title
self-management
Arm Type
Experimental
Arm Description
Participants will be taught to monitor blood pressure and make limited adjustments to their medications
Arm Title
usual care
Arm Type
No Intervention
Arm Description
Participants will be enrolled in the study and undergo a baseline, 6 month, and 1 year visit but their hypertension care will be per usual care.
Intervention Type
Other
Intervention Name(s)
self-management protocol for hypertension care
Intervention Description
participants in this arm will be taught to monitor and record their blood pressure. On a regular basis they will evaluate their blood pressure record and follow an algorithm to decide whether to adjust their medication.
Primary Outcome Measure Information:
Title
in-clinic blood pressure change
Description
Blood pressure as measured in clinic at start and end of study
Time Frame
1 year (end of intervention)
Secondary Outcome Measure Information:
Title
24-hour ambulatory blood pressure change
Description
Home (24 hour) ambulatory blood pressure change measured from start to end of study
Time Frame
1 year (start to end of intervention)
Other Pre-specified Outcome Measures:
Title
Incidence of Treatment-Emergent Adverse Events [Safety]
Description
Comparison of study-related adverse events in intervention vs. usual care arm. Events considered to be study-related include ER or urgent care visits for low or high blood pressure; hospitalizations related to low or high blood pressure; clinical events (hypertensive urgency, heart attack, stroke, syncope, death) related to high or low blood pressure.
Time Frame
1 year
Title
Intervention acceptability (patient-reported)
Description
acceptability of the intervention as measured by patient-reported scale of acceptability.
Time Frame
1 year
Title
Self-efficacy (patient-reported)
Description
Patients will report their hypertension-specific self-efficacy on a scale that will be repeated at start and end of study.
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Eligible participants are those with who have a clinical diagnosis of hypertension Who are not currently at their in-clinic goal blood pressure (>130 or > 90 at minimum) Are able to provide independent informed consent and expected to be in the area for at least 12 months Exclusion Criteria: Criteria for exclusion will include: active prescriptions for > 2 antihypertensive agents Known allergies to 2 or more antihypertensive agents Currently not primarily in charge of his/her own medication administration, e.g.: those living in institutions or with dementia or other limitations making self medication care not possible Life expectancy of less than 12 months Blood pressure at screening visit > 180 mm Hg systolic or > 110 diastolic, or < 120 systolic Screening cognitive function (Montreal Assessment of Cognitive Function, MoCA) 48 score less than 25 eGFR < 25 ml/min /1.73m2 or end-stage renal disease (ESRD) Inability to use a standard home blood pressure cuff Known secondary cause of hypertension that causes concern regarding safety of the protocol, in the opinion of the site investigator Cardiovascular event or hospitalization for unstable angina within last 3 months Symptomatic heart failure within the past 6 months or left ventricular ejection fraction < 35% Pregnancy or planned pregnancy, or of child-bearing age not using birth control Current participation in another clinical trial Or major factors judged to be likely to significantly limit comprehension of or adherence to interventions including: dementia psychiatric disease substance abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dena Evette Rifkin, MD MS
Organizational Affiliation
VA San Diego Healthcare System, San Diego, CA
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA San Diego Healthcare System, San Diego, CA
City
San Diego
State/Province
California
ZIP/Postal Code
92161-0002
Country
United States
Facility Name
San Francisco VA Medical Center, San Francisco, CA
City
San Francisco
State/Province
California
ZIP/Postal Code
94121
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
de-identified data may be shared at end of study

Learn more about this trial

Self-management of Blood Pressure Medication for Hypertensive Veterans

We'll reach out to this number within 24 hrs